Thrivent Financial for Lutherans
USNA icon

Thrivent Financial for Lutherans’s Usana Health Sciences USNA Stock Holding History

Thrivent Financial for Lutherans’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,777
Closed -$214K – 2653
2025
Q3 		$214K Sell
7,777
-165
-2% -$5.08K ﹤0.01% 2306
2025
Q2 		$242K Sell
7,942
-178
-2% -$5.05K ﹤0.01% 2356
2025
Q1 		$219K Sell
8,120
-425
-5% -$13.5K ﹤0.01% 2302
2024
Q4 		$307K Sell
8,545
-133
-2% -$4.97K ﹤0.01% 2406
2024
Q3 		$329K Sell
8,678
-495
-5% -$20.3K ﹤0.01% 2368
2024
Q2 		$415K Sell
9,173
-452
-5% -$20.8K ﹤0.01% 2289
2024
Q1 		$467K Sell
9,625
-262
-3% -$12.8K ﹤0.01% 2260
2023
Q4 		$530K Sell
9,887
-354
-3% -$17.9K ﹤0.01% 2193
2023
Q3 		$600K Sell
10,241
-466
-4% -$29.1K ﹤0.01% 2049
2023
Q2 		$675K Sell
10,707
-332
-3% -$21.1K ﹤0.01% 2044
2023
Q1 		$694K Sell
11,039
-387
-3% -$23.1K ﹤0.01% 1987
2022
Q4 		$608K Sell
11,426
-84
-0.7% -$4.55K ﹤0.01% 2028
2022
Q3 		$645K Buy
11,510
+199
+2% +$13.2K ﹤0.01% 1942
2022
Q2 		$818K Buy
11,311
+1,805
+19% +$134K ﹤0.01% 1831
2022
Q1 		$755K Buy
9,506
+3
+0% +$270 ﹤0.01% 1984
2021
Q4 		$962K Sell
9,503
-203
-2% -$20.2K ﹤0.01% 1883
2021
Q3 		$895K Buy
9,706
+276
+3% +$26.6K ﹤0.01% 1887
2021
Q2 		$966K Sell
9,430
-334
-3% -$33.5K ﹤0.01% 1868
2021
Q1 		$953K Sell
9,764
-168
-2% -$15.3K ﹤0.01% 1905
2020
Q4 		$766K Hold
9,932
– – ﹤0.01% 1930
2020
Q3 		$731K Sell
9,932
-270
-3% -$21.7K ﹤0.01% 1758
2020
Q2 		$749K Sell
10,202
-318
-3% -$24.9K ﹤0.01% 1697
2020
Q1 		$608K Buy
10,520
+525
+5% +$36.5K ﹤0.01% 1610
2019
Q4 		$785K Sell
9,995
-262
-3% -$19.3K ﹤0.01% 1621
2019
Q3 		$701K Sell
10,257
-142
-1% -$9.54K ﹤0.01% 1640
2019
Q2 		$826K Buy
+10,399
New +$825K ﹤0.01% 1532

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Thrivent Financial for Lutherans's USNA Position: Q4 2025 in Review

Thrivent Financial for Lutherans sold out of Usana Health Sciences (USNA) in Q4 2025, closing a stake of 7,777 shares — an estimated $214K sold.

Thrivent Financial for Lutherans first reported a position in USNA in Q2 2019 and held it in 26 quarters. The position peaked at $966K in Q2 2021. 121 funds tracked by Wall St. Rank hold USNA as of Q4 2025.

  • Thrivent Financial for Lutherans reported no remaining Usana Health Sciences position as of Q4 2025 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 7,777 Usana Health Sciences shares in Q4 2025, an estimated $214K.
  • Thrivent Financial for Lutherans first reported a position in Usana Health Sciences in Q2 2019 and held it in 26 quarters.
  • Thrivent Financial for Lutherans's Usana Health Sciences position peaked at $966K in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2025.

Based on Thrivent Financial for Lutherans's 13F filing for Q4 2025, filed 5 Feb 2026.